DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes
0
🏷️
Sign in to get full access
Overview
- Cancer is a leading cause of death globally, with significant heterogeneity in clinical and molecular responses to therapy.
- Molecular subtyping and precision medicine have helped address these challenges and provide insights to improve prognosis and decision-making.
- Conventional machine learning (ML) and deep learning (DL) have been widely used to classify cancer subtypes from gene expression data, but these methods can be biased toward identifying cancer biomarkers.
- The paper proposes an end-to-end deep learning approach called DeepGene Transformer that addresses the complexity of high-dimensional gene expression data using a multi-head self-attention module.
Plain English Explanation
Cancer is a serious disease that affects a large number of people globally, causing about 30% of all deaths. The different types of cancer can vary greatly in how they respond to treatment, making it challenging for doctors to determine the best course of action.
To help overcome these challenges, researchers have been using advanced machine learning and deep learning techniques to analyze gene expression data and identify the specific subtypes of cancer a patient has. This can provide valuable information about the patient's prognosis and guide the doctor's treatment decisions.
However, the current machine learning and deep learning methods used for this task can be biased towards identifying certain biomarkers, or indicators of the disease, which may not always be the most relevant or accurate.
To address this issue, the researchers in this study developed a new deep learning approach called DeepGene Transformer. This method uses a multi-head self-attention module to analyze the complex gene expression data and identify the key biomarkers that are most important for classifying the different subtypes of cancer.
By using this approach, the researchers were able to outperform the commonly used traditional and state-of-the-art classification algorithms, suggesting that DeepGene Transformer could be an efficient and effective way to help doctors better understand and treat different types of cancer.
Technical Explanation
The paper proposes a novel end-to-end deep learning approach called DeepGene Transformer to address the complexity of high-dimensional gene expression data for the classification of cancer subtypes. The model leverages a multi-head self-attention module to identify relevant biomarkers across multiple cancer subtypes without requiring feature selection as a pre-requisite.
The researchers conducted a comparative analysis to evaluate the performance of DeepGene Transformer against commonly used traditional and state-of-the-art classification algorithms, such as Comprehensive Multimodal Deep Learning for Survival Prediction, Hybrid Machine Learning Model for Classifying Gene Mutations, Predicting Genetic Mutation from Whole Slide Images, and Contrastive Learning for Predicting Cancer Prognosis Using Gene expression data. The results showed that DeepGene Transformer outperformed these algorithms, indicating its efficiency for classifying cancer and its subtypes.
Critical Analysis
The paper presents a promising approach for cancer subtype classification, but it is essential to consider some potential limitations and areas for further research.
One key limitation is the reliance on gene expression data alone, which may not capture the full complexity of cancer biology. Integrating additional data modalities, such as genomic, epigenomic, or clinical data, could potentially enhance the model's performance and provide a more comprehensive understanding of cancer subtypes.
Moreover, the paper does not extensively discuss the interpretability of the DeepGene Transformer model, which is crucial for clinical applications. Exploring the model's ability to identify and explain the most relevant biomarkers for each cancer subtype could further strengthen its utility in guiding personalized treatment strategies.
Additionally, the paper could have explored the generalizability of the DeepGene Transformer model by testing its performance on independent datasets or across different cancer types. This would help validate the model's robustness and potential for broader applicability in the field of computational oncology.
Conclusion
The proposed DeepGene Transformer model presents a promising approach for the classification of cancer subtypes, outperforming commonly used traditional and state-of-the-art algorithms. By leveraging a multi-head self-attention module to identify relevant biomarkers, this end-to-end deep learning method offers a novel way to address the complexity of high-dimensional gene expression data and potentially improve clinical decision-making in cancer treatment. However, further research is needed to explore the model's integration with multi-modal data, interpretability, and generalizability to solidify its impact on the field of computational oncology.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🏷️
0
DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes
Anwar Khan, Boreom Lee
Cancer and its subtypes constitute approximately 30% of all causes of death globally and display a wide range of heterogeneity in terms of clinical and molecular responses to therapy. Molecular subtyping has enabled the use of precision medicine to overcome these challenges and provide significant biological insights to predict prognosis and improve clinical decision-making. Over the past decade, conventional machine learning (ML) and deep learning (DL) algorithms have been widely espoused for the classification of cancer subtypes from gene expression datasets. However, these methods are potentially biased toward the identification of cancer biomarkers. Hence, an end-to-end deep learning approach, DeepGene Transformer, is proposed which addresses the complexity of high-dimensional gene expression with a multi-head self-attention module by identifying relevant biomarkers across multiple cancer subtypes without requiring feature selection as a pre-requisite for the current classification algorithms. Comparative analysis reveals that the proposed DeepGene Transformer outperformed the commonly used traditional and state-of-the-art classification algorithms and can be considered an efficient approach for classifying cancer and its subtypes, indicating that any improvement in deep learning models in computational biologists can be reflected well in this domain as well.
Read more7/11/2024
👀
0
A vision transformer-based framework for knowledge transfer from multi-modal to mono-modal lymphoma subtyping models
Bilel Guetarni, Feryal Windal, Halim Benhabiles, Marianne Petit, Romain Dubois, Emmanuelle Leteurtre, Dominique Collard
Determining lymphoma subtypes is a crucial step for better patient treatment targeting to potentially increase their survival chances. In this context, the existing gold standard diagnosis method, which relies on gene expression technology, is highly expensive and time-consuming, making it less accessibility. Although alternative diagnosis methods based on IHC (immunohistochemistry) technologies exist (recommended by the WHO), they still suffer from similar limitations and are less accurate. Whole Slide Image (WSI) analysis using deep learning models has shown promising potential for cancer diagnosis, that could offer cost-effective and faster alternatives to existing methods. In this work, we propose a vision transformer-based framework for distinguishing DLBCL (Diffuse Large B-Cell Lymphoma) cancer subtypes from high-resolution WSIs. To this end, we introduce a multi-modal architecture to train a classifier model from various WSI modalities. We then leverage this model through a knowledge distillation process to efficiently guide the learning of a mono-modal classifier. Our experimental study conducted on a lymphoma dataset of 157 patients shows the promising performance of our mono-modal classification model, outperforming six recent state-of-the-art methods. In addition, the power-law curve, estimated on our experimental data, suggests that with more training data from a reasonable number of additional patients, our model could achieve competitive diagnosis accuracy with IHC technologies. Furthermore, the efficiency of our framework is confirmed through an additional experimental study on an external breast cancer dataset (BCI dataset).
Read more5/30/2024
🤿
0
Comprehensive Multimodal Deep Learning Survival Prediction Enabled by a Transformer Architecture: A Multicenter Study in Glioblastoma
Ahmed Gomaa, Yixing Huang, Amr Hagag, Charlotte Schmitter, Daniel Hofler, Thomas Weissmann, Katharina Breininger, Manuel Schmidt, Jenny Stritzelberger, Daniel Delev, Roland Coras, Arnd Dorfler, Oliver Schnell, Benjamin Frey, Udo S. Gaipl, Sabine Semrau, Christoph Bert, Rainer Fietkau, Florian Putz
Background: This research aims to improve glioblastoma survival prediction by integrating MR images, clinical and molecular-pathologic data in a transformer-based deep learning model, addressing data heterogeneity and performance generalizability. Method: We propose and evaluate a transformer-based non-linear and non-proportional survival prediction model. The model employs self-supervised learning techniques to effectively encode the high-dimensional MRI input for integration with non-imaging data using cross-attention. To demonstrate model generalizability, the model is assessed with the time-dependent concordance index (Cdt) in two training setups using three independent public test sets: UPenn-GBM, UCSF-PDGM, and RHUH-GBM, each comprising 378, 366, and 36 cases, respectively. Results: The proposed transformer model achieved promising performance for imaging as well as non-imaging data, effectively integrating both modalities for enhanced performance (UPenn-GBM test-set, imaging Cdt 0.645, multimodal Cdt 0.707) while outperforming state-of-the-art late-fusion 3D-CNN-based models. Consistent performance was observed across the three independent multicenter test sets with Cdt values of 0.707 (UPenn-GBM, internal test set), 0.672 (UCSF-PDGM, first external test set) and 0.618 (RHUH-GBM, second external test set). The model achieved significant discrimination between patients with favorable and unfavorable survival for all three datasets (logrank p 1.9times{10}^{-8}, 9.7times{10}^{-3}, and 1.2times{10}^{-2}). Conclusions: The proposed transformer-based survival prediction model integrates complementary information from diverse input modalities, contributing to improved glioblastoma survival prediction compared to state-of-the-art methods. Consistent performance was observed across institutions supporting model generalizability.
Read more5/22/2024
0
Meta-Learning on Augmented Gene Expression Profiles for Enhanced Lung Cancer Detection
Arya Hadizadeh Moghaddam, Mohsen Nayebi Kerdabadi, Cuncong Zhong, Zijun Yao
Gene expression profiles obtained through DNA microarray have proven successful in providing critical information for cancer detection classifiers. However, the limited number of samples in these datasets poses a challenge to employ complex methodologies such as deep neural networks for sophisticated analysis. To address this small data dilemma, Meta-Learning has been introduced as a solution to enhance the optimization of machine learning models by utilizing similar datasets, thereby facilitating a quicker adaptation to target datasets without the requirement of sufficient samples. In this study, we present a meta-learning-based approach for predicting lung cancer from gene expression profiles. We apply this framework to well-established deep learning methodologies and employ four distinct datasets for the meta-learning tasks, where one as the target dataset and the rest as source datasets. Our approach is evaluated against both traditional and deep learning methodologies, and the results show the superior performance of meta-learning on augmented source data compared to the baselines trained on single datasets. Moreover, we conduct the comparative analysis between meta-learning and transfer learning methodologies to highlight the efficiency of the proposed approach in addressing the challenges associated with limited sample sizes. Finally, we incorporate the explainability study to illustrate the distinctiveness of decisions made by meta-learning.
Read more8/20/2024